newsfilter
← Latest News
Business Wire·

Kezar Life Sciences to Participate in Two Upcoming Investor Conferences

Kezar Life Sciences, Inc. (NASDAQ:KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that Chris Kirk, Chief